share_log

Oppenheimer Upgrades AtriCure to Outperform, Announces $32 Price Target

Oppenheimer Upgrades AtriCure to Outperform, Announces $32 Price Target

奧本海默將AtriCure上調至跑贏大盤,宣佈目標股價爲32美元
Moomoo 24/7 ·  04/23 07:40

Oppenheimer analyst Suraj Kalia upgrades AtriCure (NASDAQ:ATRC) from Perform to Outperform and announces $32 price target.

奧本海默分析師蘇拉傑·卡利亞將AtriCure(納斯達克股票代碼:ATRC)從表現上調至跑贏大盤,並宣佈目標股價爲32美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論